LARA TRUSHEL: Open Payments
NPI 1649463951 · ALIQUIPPA, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,557 in 81 payments from 21 companies in 2025. Trend: 2023 $1,693 · 2024 $1,767 · 2025 $1,557
Food & beverage: $1,557
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 25 | $445 |
| Novo Nordisk Inc | 11 | $264 |
| GlaxoSmithKline, LLC. | 5 | $97 |
| Abbott Laboratories | 5 | $97 |
| Lilly USA, LLC | 5 | $95 |
| PFIZER INC. | 4 | $85 |
| Astellas Pharma US Inc | 3 | $75 |
| Amgen Inc. | 3 | $56 |
| Paratek Pharmaceuticals, Inc. | 3 | $55 |
| Sumitomo Pharma America, Inc. | 2 | $39 |
Products named: QULIPTA, Wegovy, MOUNJARO, Ozempic, UBRELVY, VRAYLAR, PROCLAIM, Veozah.
Industry payments across PA — which companies pay providers there.
